CDT EQUITY INC. Debt Instrument, Fair Value Disclosure
CDT EQUITY INC. (CDT) had Debt Instrument, Fair Value Disclosure of $200.00 thousand as of 2026-03-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-07-15
- 2026-03-31: Debt Instrument, Fair Value Disclosure $200.00K.
- 2024-10-09: Debt Instrument, Fair Value Disclosure $100.00K.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2026-03-31 | $200.00K 10-Q · filed 2026-07-15 |
| 2024-10-09 | $100.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |